Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 234

1.

External Quality Assessment for Zika Virus Molecular Diagnostic Testing, Brazil.

Baylis SA, Blümel J.

Emerg Infect Dis. 2018 Oct;24(10):1966. doi: 10.3201/eid2410.180360. No abstract available.

2.

External Quality Assessment (EQA) for Molecular Diagnostics of Zika Virus: Experiences from an International EQA Programme, 2016⁻2018.

Donoso Mantke O, McCulloch E, Wallace PS, Yue C, Baylis SA, Niedrig M.

Viruses. 2018 Sep 13;10(9). pii: E491. doi: 10.3390/v10090491. Review.

3.

CD4+T cells mediate protection against Zika associated severe disease in a mouse model of infection.

Hassert M, Wolf KJ, Schwetye KE, DiPaolo RJ, Brien JD, Pinto AK.

PLoS Pathog. 2018 Sep 13;14(9):e1007237. doi: 10.1371/journal.ppat.1007237. eCollection 2018 Sep.

4.

The Challenges Imposed by Dengue, Zika, and Chikungunya to Brazil.

Zanotto PMA, Leite LCC.

Front Immunol. 2018 Aug 28;9:1964. doi: 10.3389/fimmu.2018.01964. eCollection 2018. Review.

5.

Comparative genomics, infectivity and cytopathogenicity of Zika viruses produced by acutely and persistently infected human hematopoietic cell lines.

Li B, Liao HM, Liu H, Tsai S, Zhang J, Hung GC, Chin PJ, Gao Y, Lo SC.

PLoS One. 2018 Sep 7;13(9):e0203331. doi: 10.1371/journal.pone.0203331. eCollection 2018.

6.

Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus.

Saiz JC, Oya NJ, Blázquez AB, Escribano-Romero E, Martín-Acebes MA.

Viruses. 2018 Aug 24;10(9). pii: E453. doi: 10.3390/v10090453. Review.

7.

Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge.

Cox F, van der Fits L, Abbink P, Larocca RA, van Huizen E, Saeland E, Verhagen J, Peterson R, Tolboom J, Kaufmann B, Schuitemaker H, Barouch DH, Zahn R.

PLoS One. 2018 Aug 24;13(8):e0202820. doi: 10.1371/journal.pone.0202820. eCollection 2018.

8.

Risk of Zika virus transmission by blood donations in Brazil.

Magnus MM, Espósito DLA, Costa VAD, Melo PS, Costa-Lima C, Fonseca BALD, Addas-Carvalho M.

Hematol Transfus Cell Ther. 2018 Jul-Sep;40(3):250-254. doi: 10.1016/j.htct.2018.01.011. Epub 2018 Apr 23.

9.
10.

Sero-prevalence of yellow fever and related Flavi viruses in Ethiopia: a public health perspective.

Mengesha Tsegaye M, Beyene B, Ayele W, Abebe A, Tareke I, Sall A, Yactayo S, Shibeshi ME, Staples E, Belay D, Lilay A, Alemu A, Alemu E, Kume A, H/Mariam A, Ronveaux O, Tefera M, Kassa W, Bekele Weyessa A, Jima D, Kebede A, Tayachew A.

BMC Public Health. 2018 Aug 14;18(1):1011. doi: 10.1186/s12889-018-5726-9.

11.

Functional Genomics and Immunologic Tools: The Impact of Viral and Host Genetic Variations on the Outcome of Zika Virus Infection.

Yun SI, Song BH, Frank JC, Julander JG, Olsen AL, Polejaeva IA, Davies CJ, White KL, Lee YM.

Viruses. 2018 Aug 11;10(8). pii: E422. doi: 10.3390/v10080422.

12.

Exhaustive TORCH Pathogen Diagnostics Corroborate Zika Virus Etiology of Congenital Malformations in Northeastern Brazil.

Moreira-Soto A, Cabral R, Pedroso C, Eschbach-Bludau M, Rockstroh A, Vargas LA, Postigo-Hidalgo I, Luz E, Sampaio GS, Drosten C, Netto EM, Jaenisch T, Ulbert S, Sarno M, Brites C, Drexler JF.

mSphere. 2018 Aug 8;3(4). pii: e00278-18. doi: 10.1128/mSphere.00278-18.

13.

Zika virus infects human testicular tissue and germ cells.

Matusali G, Houzet L, Satie AP, Mahé D, Aubry F, Couderc T, Frouard J, Bourgeau S, Bensalah K, Lavoué S, Joguet G, Bujan L, Cabié A, Avelar G, Lecuit M, Le Tortorec A, Dejucq-Rainsford N.

J Clin Invest. 2018 Sep 10. pii: 121735. doi: 10.1172/JCI121735. [Epub ahead of print]

14.

Infection-control knowledge, attitude, practice, and risk perception of occupational exposure to Zika virus among nursing students in Korea: A cross-sectional survey.

Choi JS, Kim KM.

J Infect Public Health. 2018 Jul 23. pii: S1876-0341(18)30106-0. doi: 10.1016/j.jiph.2018.07.002. [Epub ahead of print]

15.

A VSV-based Zika virus vaccine protects mice from lethal challenge.

Emanuel J, Callison J, Dowd KA, Pierson TC, Feldmann H, Marzi A.

Sci Rep. 2018 Jul 23;8(1):11043. doi: 10.1038/s41598-018-29401-x.

16.

Toll-like receptor agonist R848 blocks Zika virus replication by inducing the antiviral protein viperin.

Vanwalscappel B, Tada T, Landau NR.

Virology. 2018 Sep;522:199-208. doi: 10.1016/j.virol.2018.07.014. Epub 2018 Jul 20.

17.

Mapping Putative B-Cell Zika Virus NS1 Epitopes Provides Molecular Basis for Anti-NS1 Antibody Discrimination between Zika and Dengue Viruses.

Freire MCLC, Pol-Fachin L, Coêlho DF, Viana IFT, Magalhães T, Cordeiro MT, Fischer N, Loeffler FF, Jaenisch T, Franca RF, Marques ETA, Lins RD.

ACS Omega. 2017 Jul 31;2(7):3913-3920. doi: 10.1021/acsomega.7b00608. Epub 2017 Jul 25.

18.

Detecting Local Zika Virus Transmission in the Continental United States: A Comparison of Surveillance Strategies.

Russell S, Ryff K, Gould C, Martin S, Johansson M.

PLoS Curr. 2017 Nov 22;9. pii: ecurrents.outbreaks.cd76717676629d47704170ecbdb5f820. doi: 10.1371/currents.outbreaks.cd76717676629d47704170ecbdb5f820.

19.

Pregnant women co-infected with HIV and Zika: Outcomes and birth defects in infants according to maternal symptomatology.

João EC, Ferreira ODC Jr, Gouvêa MI, Teixeira MLB, Tanuri A, Higa LM, Costa DA, Mohana-Borges R, Arruda MB, Matos HJ, Cruz ML, Mendes-Silva W, Read JS.

PLoS One. 2018 Jul 6;13(7):e0200168. doi: 10.1371/journal.pone.0200168. eCollection 2018.

20.

Complete Genome Sequences of Zika Virus Strains Used for the Formulation of CBER/FDA RNA Reference Reagents and Lot Release Panels for Nucleic Acid Technology Testing.

Volkova E, Grinev A, Fares-Gusmao R, Chancey C, Rios M.

Genome Announc. 2018 Jul 5;6(27). pii: e00572-18. doi: 10.1128/genomeA.00572-18.

Supplemental Content

Loading ...
Support Center